International survey on frailty assessment in patients with cancer
Name:
oyac133.pdf
Size:
603.3Kb
Format:
PDF
Description:
Identified with Open Access button
Authors
Banna, G. L.Cantale, O.
Haydock, M. M.
Battisti, N. M. L.
Bambury, K.
Musolino, N.
E, O. C.
Maltese, G.
Garetto, L.
Addeo, A.
Gomes, Fabio
Affiliation
Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, ItalyIssue Date
2022
Metadata
Show full item recordAbstract
Background: Frailty negatively affects the outcomes of patients with cancer, and its assessment might vary widely in the real world. The objective of this study was to explore awareness and use of frailty screening tools among the ONCOassist healthcare professionals (HCPs) users. Materials and methods: We sent 2 emails with a cross-sectional 15-item survey in a 3-week interval between April and May 2021. Differences in the awareness and use of tools according to respondents' continents, country income, and job types were investigated. Results: Seven hundred thirty-seven HCPs from 91 countries (81% physicians, 13% nurses, and 5% other HCPs) completed the survey. Three hundred and eighty-five (52%) reported assessing all or the majority of their patients; 518 (70%) at baseline and before starting a new treatment. Three hundred and four (43%) HCPs were aware of performance status (PS) scores only, 309 (42%) age/frailty/comorbidity (AFC) screening, and 102 (14%) chemotoxicity predictive tools. Five hundred and thirty-seven (73%) reported using tools; 423 (57%) just PS, 237 (32%) AFC, and 60 (8%) chemotoxicity ones. Reasons for tools non-use (485 responders) were awareness (70%), time constraints (28%), and uselessness (2%). There were significant differences in awareness and use of screening tools among different continents, country income, job types, and medical specialties (P < .001 for all comparisons). Conclusion: Among selected oncology HCPs, there is still a worldwide lack of knowledge and usage of frailty screening tools, which may differ according to their geography, country income, and education. Targeted initiatives to raise awareness and education are needed to implement frailty assessment in managing patients with cancer.Citation
Banna GL, Cantale O, Haydock MM, Battisti NML, Bambury K, Musolino N, et al. International Survey on Frailty Assessment in Patients with Cancer. Oncologist. 2022 Jul 29. PubMed PMID: 35905085. Epub 2022/07/30. eng.Journal
OncologistDOI
10.1093/oncolo/oyac133PubMed ID
35905085Additional Links
https://dx.doi.org/10.1093/oncolo/oyac133Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1093/oncolo/oyac133
Scopus Count
Collections
Related articles
- Safety Communication Tools and Healthcare Professionals' Awareness of Specific Drug Safety Issues in Europe: A Survey Study.
- Authors: de Vries ST, van der Sar MJM, Coleman AM, Escudero Y, Rodríguez Pascual A, Maciá Martínez MÁ, Cupelli A, Baldelli I, Šipić I, Andrić A, Michan L, Denig P, Mol PGM, SCOPE work package 6
- Issue date: 2018 Jul
- Identifying and Managing Frailty: A Survey of UK Healthcare Professionals.
- Authors: Frost R, Robinson K, Gordon A, Caldeira de Melo R, Villas Boas PJF, Azevedo PS, Hinsliff-Smith K, Gavin JP
- Issue date: 2024 Apr
- Evaluation of awareness and understanding of cancer immunotherapy among healthcare professionals in eastern Saudi Arabia.
- Authors: Hamad RS
- Issue date: 2020 Sep
- Screening tools to expedite assessment of frailty in people receiving haemodialysis: a diagnostic accuracy study.
- Authors: Zanotto T, Mercer TH, van der Linden ML, Koufaki P
- Issue date: 2021 Jul 2
- Description of frail older people profiles according to four screening tools applied in primary care settings: a cross sectional analysis.
- Authors: Vergara I, Mateo-Abad M, Saucedo-Figueredo MC, Machón M, Montiel-Luque A, Vrotsou K, Nava Del Val MA, Díez-Ruiz A, Güell C, Matheu A, Bueno A, Núñez J, Rivas-Ruiz F
- Issue date: 2019 Dec 3